# A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America

> **NCT05857397** · — · ACTIVE_NOT_RECRUITING · sponsor: **Latin American Cooperative Oncology Group** · enrollment: 64 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **OTHER:** Observational study

## Key facts

- **NCT ID:** NCT05857397
- **Lead sponsor:** Latin American Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-21
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05857397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05857397, "A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05857397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*